Skip to Content
Søk Menu

Health-related quality of life is associated with clinical outcomes in patients with advanced renal cell carcinoma

Is there a direct association between health-related quality of life (HRQoL) in patients with advanced renal cell carcinoma? This correlation is what the updated Checkmate-214, presented at ASCO22, uncovers.

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Daniel Heinrich

Highlights from ESMO 2024: More Intelligent Choice of Treatment in the Future

/ Daniel Heinrich
BlærekreftESMO24NyrekreftProstatakreft Play the Video 4:25
Katriina Jalkanen

Belzutifan is Well-Tolerated and Might Be an Addition to a Standard of Care

/ Katriina Jalkanen
ESMO24Nyrekreft Play the Video 04:33
Umang Swami

Single-Agent Cabozantinib is Sufficient and Avoids Extra Toxicity in Metastatic Clear Cell Renal Cell Carcinoma Patients

/ Umang Swami
Nyrekreft Play the Video 06:01

Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors

/ Niels Fristrup
Nyrekreft

Nivolumab + Cabozantinib Remains Standard of Care in First-Line Treatment for Advanced Renal Cell Carcinoma

/ Sofie Pohl
Nyrekreft
Maria Teresa Bourlon

Nivolumab + Cabozantinib Remains Standard of Care in First-Line Treatment for Advanced Renal Cell Carcinoma

/ Maria Teresa Bourlon
Nyrekreft Play the Video 5:36
Wadih Issa

Comparing Downstaging in RCC-Patients with Tumor or Without Tumor Thrombus Receiving Neoadjuvant ICI Regimen

/ Wadih Issa
ASCOGU24Nyrekreft Play the Video 1:47
Marc Machaalani

Host Immune Signatures as Predictors for Immunotherapy Regimens in Patients with Metastatic Renal Cell Carcinoma

/ Marc Machaalani
Nyrekreft Play the Video 2:11
Eddy Saad

Understanding Mechanisms Behind Acquired Resistance to Immunotherapy in Metastatic Renal Cell Carcinoma

/ Eddy Saad
ASCOGU24Nyrekreft Play the Video 2:21
Back to top